| Original language | English (US) |
|---|---|
| Pages (from-to) | 675 |
| Number of pages | 1 |
| Journal | JACC: Heart Failure |
| Volume | 2 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2014 |
Funding
Please note: Dr. Storrow has received grant support from Abbott Diagnostics , NIH / NHLBI (K23HL085387 and K12HL1090), National Center for Advancing Translational Sciences ( UL1TR000445 ), Centers for Disease Control, and Roche Diagnostics . He consults for Roche Diagnostics, Abbott Point-of-Care, Astellas, and Novartis Pharmaceuticals Corp, USA. Dr. Barrett is supported by grant K23HL102069 and serves as a consultant for Red Bull GmbH. Dr. Collins receives research funding from NIH / NHLBI , Medtronic , Cardiorentis , Abbott Point-of-Care , Novartis , The Medicines Company , and Radiometer and consults with Trevena, Novartis, Otsuka, Radiometer, The Medicines Company, Medtronic, and Astellas. Dr. Self has received research funding from the Centers for Disease Control and Prevention , the NIH, Affinium Pharmaceuticals , bioMerieux , Astute Medical , and CareFusion Inc . Dr. Han is supported by funding from the Emergency Medicine Foundation Career Development Award and NIH K23AG032355 , and the National Center for Advancing Translational Sciences UL1 TR000445 . Dr. Gheorghiade has received consulting fees from Bayer, Novartis, Sigma Tau, Johnson & Johnson, Takeda, Otsuka, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine